Requires Adobe Acrobat Reader

Table 13.12

Adjusted Patient Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

		3 Months			1 Year			5 Years			10 Years
		(Tx 2005 - 2006)			(Tx 2005 - 2006)			(Tx 2001 - 2006)			(Tx 1996 - 2006)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	65	80.5%	4.9%	65	74.4%	5.4%	188	46.8%	4.8%	425	28.2%	3.2%
Primary Diagnosis	Congenital Disease	14	53.5%	13.6%	14	53.5%	13.6%	53	46.9%	7.2%	157	25.8%	4.5%
	Primary Pulmonary Hypertension	19	85.4%	7.9%	19	85.4%	7.9%	55	60.3%	8.6%	97	38.7%	7.7%
	Cystic Fibrosis	2	+	+	2	+	+	5	0.0%	0.0%	12	34.4%	14.5%
	Emphysema/COPD	1	100.0%	0.0%	1	0.0%	0.0%	2	0.0%	0.0%	14	31.4%	12.2%
	Other	9	89.3%	9.9%	9	78.5%	13.6%	23	46.2%	12.1%	39	23.8%	9.5%
	Unknown	20	85.6%	7.6%	20	75.9%	9.5%	50	42.3%	9.5%	106	22.1%	7.0%

Source: OPTN/SRTR Data as of May 1, 2008.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.

Requires Adobe Acrobat Reader